Article Information
Author Information
- Kathleen I. Pritchard,
- Mark Levine,
- Barbara Walley
- Head Division of Clinical Trials and Epidemiology Toronto-Sunnybrook Regional Cancer Centre Toronto, Ont.; Professor Department of Medicine McMaster University Hamilton, Ont.; Medical oncologist Saskatoon Cancer Centre Saskatoon, Sask. on behalf of the Ad Hoc Raloxifene in Breast Cancer Group Members of the Ad Hoc Raloxifene in Breast Cancer Group: Dr. Hasmin Alam Zeenat, Dr. Margot Burnell, Martin Blackstein, Dr. Bruce Colwell, Dr. Susan Dent, Dr. Karen Gelmon, Dr. Paul Goss, Dr. Kara Laing, Dr. Mark Levine, Dr. Lavina Lickley, Dr. Kathleen Pritchard, Dr. Andre Robidoux, Dr. Ted Vandenberg, Dr. Shaill Verma, Dr. Barbara Walley